Resumen de Investigación
Analyzed using Evidence Intelligence™

Metformin improves fat oxidation and reduces visceral fat in type 2 diabetes.

Última actualización 24 de agosto de 2026

Key finding

Post-prandial plasma lactate concentration was significantly increased after the metformin treatment.

This study examined the effects of metformin on energy metabolism and body composition in human subjects and rats, finding significant changes in metabolic markers.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study examined the effects of metformin on energy metabolism and body composition in human subjects and rats, finding significant changes in metabolic markers.

Clinical relevance

These findings are significant as they highlight metformin's potential role in improving metabolic health and managing obesity in diabetic patients. Understanding how metformin affects energy metabolism can help clinicians optimize treatment strategies for individuals with metabolic disorders.

Keep in mind

Limited sample size may affect generalizability. Results may not apply to non-diabetic populations. Short duration of the study may not capture long-term effects.

Published in

Referencia de la Revista

Publication details and source links for this paper.

Ichiro T, Yuji T, Shimpei I, et al. Effects of Metformin on Energy Metabolism and Anthropometric Factors in Human Subjects and Rats. PLOS ONE. 2017;12(2):e0171293. doi:10.1371/journal.pone.0171293

Efectos Principales

Post-prandial plasma lactate increased by 1.5 mmol/L (p=0.01).

Baseline respiratory quotient decreased by 0.2 (p=0.05).

Visceral fat mass reduced by 1.5 cm³ (p=0.001).

Body mass index (BMI) decreased by 0.6 kg/m² in diabetic patients (p=0.0001).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Metformin and Baseline respiratory quotient (RQ), Body weight, Change in Resting Energy Expenditure (REE), and 3 more.

Primary intervention

Metformin

Primary outcomes

  • Baseline respiratory quotient (RQ)
  • Body weight
  • Change in Resting Energy Expenditure (REE)

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

6
Evidence pairs
6
Relationships
2
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 64

2

Related topics

6

Evidence pairs

346

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 6 evidence relationships
  • Includes primary outcome data
  • Linked to 2 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Agrega evidencia relacionada a tu Evidence Tracker

Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.

Evidencia principal

Relación de evidencia

Metformin Therapies and Body Weight

Evidencia relacionada

Tema de evidencia

Weight Loss

Guardar evidencia

Tema de evidencia

Metformin

Guardar evidencia

Core evidence

Study findings

The primary outcomes reported in this study.

Baseline respiratory quotient (RQ)

Metformin → Baseline respiratory quotient (RQ)

Metformin → Baseline respiratory quotient (RQ)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Body weight

Metformin → Body weight

Metformin → Body weight

Evidence Intelligence™
EvidenceScore™
Strong
Score 79 · Based on 4 studies
ImpactScore™
75
Positive
ConsistencyScore™
35
mixed
Estudios de apoyo: Basado en 4 estudios
Add to Evidence Tracker

Change in Resting Energy Expenditure (REE)

Metformin → Change in Resting Energy Expenditure (REE)

Metformin → Change in Resting Energy Expenditure (REE)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Percentage change in visceral fat mass

Metformin → Percentage change in visceral fat mass

Metformin → Percentage change in visceral fat mass

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Post-prandial respiratory quotient (RQ)

Metformin → Post-prandial respiratory quotient (RQ)

Metformin → Post-prandial respiratory quotient (RQ)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Postprandial plasma lactate

Metformin → Postprandial plasma lactate

Metformin → Postprandial plasma lactate

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

La Evidencia Sugiere

  • Metformin significantly increased post-prandial lactate levels.
  • It reduced visceral fat mass by 1.5 cm³.
  • Diabetic patients experienced a significant BMI decrease of 0.6 kg/m².
who this applies

A quién se aplica

  • Diabetic patients undergoing treatment.
  • Healthy individuals interested in metabolic health.
keep in mind

Tener en Cuenta

  • Results are based on a specific population and may not be universally applicable.
  • Further studies are needed to confirm long-term effects.
  • The study design limits the ability to draw causal conclusions.
between the lines

Entre Líneas

  • Limited sample size may affect generalizability.
  • Results may not apply to non-diabetic populations.
  • Short duration of the study may not capture long-term effects.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Metformin Therapies and Body Weight, Metformin Therapies and Baseline respiratory quotient (RQ).

Relaciones de evidencia relacionadas

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Do Metformin Therapies affect body weight?

Strong Evidence

Metformin Therapies may affect body weight.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

  1. 1

    Body weight

    EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Mixed | 1 study

Why this answer: This answer is based on 6 supporting studies with generally consistent results and a positive effect signal.

6 supporting studies

Does Metformin improve baseline respiratory quotient (RQ)?

Emerging Evidence

Metformin appears to improve baseline respiratory quotient (RQ).

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Baseline respiratory quotient (RQ)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Metformin improve percentage change in visceral fat mass?

Emerging Evidence

Metformin appears to improve percentage change in visceral fat mass.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Percentage change in visceral fat mass

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study

Does Metformin improve post-prandial respiratory quotient (RQ)?

Emerging Evidence

Metformin appears to improve post-prandial respiratory quotient (RQ).

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Post-prandial respiratory quotient (RQ)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Sin anuncios. Sin rastreo.

Centrada en la evidencia, no en la publicidad.

Segura y privada

Tus datos siempre están protegidos.

Siempre al día

Se agregan nuevos estudios todos los días.